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Author Guidelines                                                                                            
 
1. Submission of Manuscript: 
Authors should submit electronic version (Microsoft word doc) of the manuscript through online 
submission (Recommended) or by E-mail (Mail complete manuscript to editor.ijapa@gmail.com  ). 
Accepted papers will be acknowledged and processed further, if the papers are rejected, the decision will 
be communicated to the corresponding author but the manuscripts will not be returned. 
Acceptance or rejection of the manuscript would be decided after the decision of editorial team. 
Acceptance or rejection of the manuscript for publication in journal would be informed to corresponding 
author shortly from the date of submission. 
 
Copyright form: Upon acceptance of an article, authors will be asked to transfer copyright. This 
transfer will ensure the widest possible dissemination of information.  
 
Informed Consent 
The papers comply with the clinical trials informed consent should be obtained from the participants or 
human healthy volunteers or Patients or in the case of minors the consent should be obtained from the 
parents. This should be indicated in the article in the method section. 
Ethics 
Studies reporting the experiments on human subjects and animals, procedures should be followed 
standard guidelines and authors should indicate whether the procedures followed as the guidelines and 
ethical standards. The study should be obtained the ethical clearances from the ethical committee. 
Author should indicate the ethical clearance number or project /proposal approval number in the method 
section. If needed by the journal editorial board the authors should produce the copy of ethical 
clearance. 
 
2. Preparing a Manuscript: 
Manuscripts should be prepared as word processing documents on A4, or Letter size paper, leaving a 
liberal margin (2 cm) on all four sides which should be in single-column format. The manuscript should 
be typed single-spaced throughout including references and tables. All figures and tables should be in 
the text. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you 
are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid 
is used, use tabs, not spaces, to align columns. 
Fonts: Times New Roman and point size should be 12. 
Authors should keep their manuscripts as short as they reasonably can (the total number of words 
should not exceed 3200).  Page number should appear in the upper right hand corner of each page, 
beginning with the title page. The language of manuscript must be simple and explicit. Author’s / Co-
author’s name or any other identification should not appear anywhere in the body of the manuscript to 
facilitate blind review. 
We accept manuscript under following categories: Original Research Articles, Review, Short 
communications, Case reports, Letter to Editor. 
 
Original Research Articles: It should be arranged into the following sections: 
Subdivision - numbered sections: 
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 
(then 1.1.1, 1.1.2 ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering 
also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief 
heading. Each heading should appear on its own separate line. 
Title page 
It should be paginated as page 1 of the paper. It should carry the title, authors’ names and their 
affiliations, running title, address for correspondence including e-mail address. 
Title: 
Must be informative, specific and short and not exceed 100 characters. 
Authors and affiliations: 
The names of authors and their appropriate addresses, along with individual mail id should be given. It 
should be made clear which address relates to which author. 
Address for correspondence: 
The corresponding author’s address should be given in the title page. The fax number (if available) may 
be mentioned. The e-mail ID of the corresponding author or the contact e-mail ID must also be 
provided. 
Abstract and key words 
It must start on a new page carrying the following information: 
(a) Title (without authors’ names or affiliations), 
(b) Abstract body- It should not exceed 250 words excluding the title and the key words. The abstract 
must be concise, clear and informative rather than indicative. The abstract must be in a structured form 
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consisting of objectives, methods, results and conclusions briefly explaining what was intended, done, 
observed and concluded. Authors should state the main conclusions clearly and not in vague statements. 
The conclusions and recommendations not found in the text of the article should not be given in the 
abstract. 
(c) Key words- Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the 
study. The words found in title need not be given as key words. 
 
Introduction  
(All headings: Lowercase and bold, Reference numbers1-3 to appear as superscript), (Times New Roman 
12 font size) 
It should start on a new page. Essentially this section must introduce the subject and briefly say how the 
idea for research originated. Give a concise background of the study. Do not review literature 
extensively but provide the most recent work that has a direct bearing on the subject. Justification for 
research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the 
study should be stated at the end. It should not exceed 500 words. 
Material and Methods 
(All sub-headings: Lowercase and bold, Reference numbers should appear as superscript), (Times New 
Roman 12 font size) 
This section should deal with the materials used and the methodology - how the work was carried out. 
The procedure adopted should be described in sufficient detail to allow the study to be interpreted and 
repeated by the readers, if necessary. The number of subjects, the number of groups studied, the study 
design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical 
aspects must be mentioned under the section. The methodology - the data collection procedure - must 
be described in sufficient detail. If a procedure is a commonly used one, giving a reference (previously 
published) would suffice. If a method is not well known (though previously published) it is better to 
describe it briefly. Give explicit descriptions of modifications or new methods so that the readers can 
judge their accuracy, reproducibility and reliability. 
The nomenclature, the source of material and equipment used, with details of the manufacturers in 
parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their 
non-proprietary names or generic names. If necessary, the proprietary or commercial name may be 
inserted once in parentheses. In case of pharmaceuticals, the first letter of the drug name should be 
small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., 
Persantin, Inderal). The routes of administration may be abbreviated, e.g., intraarterial (i.a.), 
intracerebroventricular (i.c.v.), intra-gastric lavage (i.g.), intramuscular (i.m.), intraperitoneal (i.p.), 
intravenous (i.v.), per os (p.o.), subcutaneous (s.c.), transdermal (t.d.). 
Statistical Methods 
The details of statistical tests used and the level of significance should be stated. If more than one test is 
used it is important to indicate which groups and parameters have been subjected to which test. 
Results  
(All sub-headings: Lowercase and bold, Reference numbers should appear as superscript), (Times New 
Roman 12 font size) 
The results should be stated concisely without comments. It should be presented in logical sequence in 
the text with appropriate reference to tables and/or figures. The data given in tables or figures should 
not be repeated in the text. The same data should not be presented in both tabular and graphic forms. 
Simple data may be given in the text itself instead of figures or tables. Avoid discussions and conclusions 
in the results section. 
Discussion  
(All sub-headings: Lowercase and bold; Reference numbers should appear as superscript), (Times New 
Roman 12 font size) 
This section should deal with the interpretation, rather than recapitulation of results. It is important to 
discuss the new and significant observations in the light of previous work. Discuss also the weaknesses 
or pitfalls in the study. New hypotheses or recommendations can be put forth. 
Avoid unqualified statements and conclusions not completely supported by the data. Repetition of 
information given under Introduction and Results should be avoided. Conclusions must be drawn 
considering the strengths and weaknesses of the study. They must be conveyed in the last paragraph 
under Discussion. Make sure conclusions drawn should tally with the objectives stated under 
Introduction. 
Acknowledgements 
It should be typed in a new page. Acknowledge only persons who have contributed to the scientific 
content or provided technical support. Sources of financial support should be mentioned. 
References  
(All sub-headings: Lowercase and bold, Reference numbers should appear as superscript), (Times New 
Roman 12 font size)                                        
It should begin on a new page. Avoid citing abstracts as references. 
Papers which have been submitted and accepted but not yet published may be included in the list of 
references with the name of the journal and indicated as “In press”. A photocopy of the acceptance 
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letter should be submitted with the manuscript. Information from manuscript “submitted” but “not yet 
accepted” should not be included. 
Avoid using abstracts as references. The “unpublished observations” and “personal communications” 
may not be used as references but may be inserted (in parentheses) in the text. 
References are to be cited in the text by superscribed number and should be in the order in which they 
appear. References cited only in tables or in legends to figures should be numbered in accordance with a 
sequence established by the first identification in the text of the particular table or illustration. 
The references must be verified by the author(s) against the original documents. The list of references 
should be typed double spaced following the Vancouver style. 
 
Examples are given in Annexure I. 
Tables 
Each table must be self-explanatory and presented in such a way that they are easily understandable 
without referring to the text. It should be typed with double spacing and numbered consecutively with 
Arabic numerals. Provide a short descriptive caption above each table with foot notes and/or 
explanations underneath. The number of observations, subjects and the units of numerical figures must 
be given. It is also important to mention whether the given values are mean, median, mean±SD or 
mean±SEM. All significant results must be indicated using asterisks. Appropriate positions for the tables 
within the text may be indicated. 
Figures 
Each figure must be numbered and a short descriptive caption must be provided. All significant results 
should be indicated using asterisks. For graphs and flow charts, it is not necessary to submit the 
photographs. A manually prepared or computer drawn figure (with good contrast) on a good quality 
paper is acceptable. Identify each figure/diagrams on the back with a typed label which shows the 
number of the figure, the name of the leading author, the title of the manuscript and the top side of the 
figure. The approximate position of each figure should be marked on the margin of the text. 
Legends for figures should be typed under the figure if possible or on a separate sheet. 
Large/complex tables or figures may be submitted in “Final Print (camera ready) format” which will be 
scanned as such. 
 
Review articles 
These should contain title page, summary (need not be structured) and key words. The text proper 
should be written under appropriate sub-headings. The authors are encouraged to use flowcharts, 
boxes, cartoons, simple tables and figures for better presentation. The total number of text words should 
not exceed 5000 and the total number of figures and tables should not be more than 10. 
 
Short communications 
The manuscript should not be divided into sub-sections. It may have up to 1200 words (including a 
maximum of 5 references) and one figure or one table. 
 
Letter to the Editor 
A letter can have a maximum of 800 words (including a maximum of 4 references) with one simple 
figure or table. The manuscript should not have sub-sections. 
 
Methods 
The format and other requirements are same as that of short communication. 
 
ANNEXURE I 
EXAMPLES OF REFERENCES - VANCOUVER STYLE 
From Uniform Requirements for Manuscripts, www.icmje.org 
Articles in Journals 
1.    Standard journal article 
List the first six authors followed by et al. (Note: NLM now lists up through 25 authors; if there are more 
than 25 authors, NLM lists the first 24, then the last author, then et al.) 
Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary 
disease. Ann Intern Med 1996 Jun 1; 124(11):980-3. 
As an option, if a journal carries continuous pagination throughout a volume (as many medical journals 
do) the month and issue number may be omitted. 
(Note: For consistency, the option is used throughout the examples in Uniform Requirements. NLM does 
not use the option.) 
Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary 
disease. Ann Intern Med 1996; 124: 980-3. 
 
More than six authors: 
Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood leukaemia in Europe 
after Chernobyl: 5 year follow-up. Br J Cancer 1996; 73:1006-12. 
2.    Organization as author 
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The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and 
performance  
guidelines. Med J Aust 1996; 164: 282-4. 
3.    No author given 
Cancer in South Africa [editorial]. S Afr Med J 1994;84:15. 
4.    Article not in English 
(Note: NLM translates the title to English, encloses the translation in square brackets, and adds an 
abbreviated language designator.) Ryder TE, Haukeland EA, Solhaug JH. Bilateral infrapatellar 
seneruptur hostidligere frisk kvinne. Tidsskr Nor Laegeforen 1996;116:41-2. 
5.    Volume with supplement 
Shen HM, Zhang QF. Risk assess-ment of nickel carcinogenicity and occupational lung cancer. Environ 
Health Perspect 1994;102 Suppl 1:275-82. 
6.    Issue with supplement 
Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 
1996; 23(1 Suppl 2):89-97. 
7.    Volume with part 
Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes 
mellitus. Ann Clin Biochem 1995;32(Pt 3):303-6. 
8.    Issue with part 
Poole GH, Mills SM. One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z 
Med J 1994;107(986 Pt 1):377-8. 
9.    Issue with no volume 
Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin 
Orthop 1995;(320):110-4. 
10.    No issue or volume 
Browell DA, Lennard TW. Immuno-logic status of the cancer patient and the effects of blood transfusion 
on antitumor responses. Curr Opin Gen Surg 1993:325-33. 
11.    Pagination in Roman numerals 
Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction. Hematol Oncol 
Clin North Am 1995 Apr;9(2):xi-xii. 
12.    Type of article indicated as needed 
Enzensberger W, Fischer PA. Metronome in Parkinson's disease [letter]. Lancet 1996;347:1337. Clement 
J, De Bock R. Hematological complications of hantavirus nephro-pathy (HVN) [abstract]. Kidney Int 
1992;42:1285. 
13.    Article containing retraction 
Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Ceruloplasmin gene defect associated with epilepsy in 
EL mice [retraction of Garey CE, Schwarzman AL, Rise ML, Seyfried TN. In: Nat Genet 1994;6:426-31]. 
Nat Genet 1995;11:104. 
14.    Article retracted 
Liou GI, Wang M, Matragoon S. Precocious IRBP gene expression during mouse development [retracted 
in Invest Ophthalmol Vis Sci 1994; 35:3127]. Invest Ophthalmol Vis Sci 1994;35:1083-8. 
15.    Article with published erratum 
Hamlin JA, Kahn AM. Herniography in symptomatic patients following inguinal hernia repair [published 
erratum appears in West J Med 1995;162:278]. West J Med 1995;162: 28-31. Books and Other 
Monographs (Note: Previous Vancouver style incorrectly had a comma rather than a semicolon between 
the publisher and the date.) 
16.    Personal author(s) 
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar 
Publishers; 1996. 
17.    Editor(s), compiler(s) as author 
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 
1996. 
18.    Organization as author and publisher 
Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 
1992. 
19.    Chapter in a book 
(Note: Previous Vancouver style had a colon rather than a p before pagination.) Phillips SJ, Whisnant JP. 
Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hyperten-sion: pathophysiology, 
diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78. 
20.    Conference proceedings 
Kimura J, Shibasaki H, editors. Recent advances in clinical neuro-physiology. Proceedings of the 10th 
International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. 
Amsterdam: Elsevier; 1996. 
21.    Conference paper 
Bengtsson S, Solheim BG. Enforce-ment of data protection, privacy and security in medical informatics. 
In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Procee-dings of the 7th World 
Congress on Medical Infor-matics; 1992 Sep 6-10; Geneva, 
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22.    Scientific or technical report 
Issued by funding/sponsoring agency: Smith P, Golladay K. Payment for durable medical equipment 
billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services 
(US), Office of Evaluation and Inspections; 1994 Oct. Report No.: HHSIGOEI69200860. Issued by 
performing agency: Field MJ, Tranquada RE, Feasley JC, editors. Health services research: work force 
and educational issues. Washington: National Academy Press; 1995. Contract No.: AHCPR282942008. 
Sponsored by the Agency for Health Care Policy and Research. 
23.    Dissertation 
Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis 
(MO): Washington Univ.; 1995. 
24.    Patent 
Larsen CE, Trip R, Johnson CR, in-ventors; Novoste Corporation, assignee. Methods for procedures re-
lated to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun  
25. Other Published Material Newspaper article 
Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. The 
Washington Post 1996 Jun 21;Sect. A:3 (col. 5). 
26.    Audiovisual material 
HIV+/AIDS: the facts and the future [videocassette]. St. Louis (MO): Mosby-Year Book; 1995. 
27.    Legal material Public law: 
Preventive Health Amendments of 1993, Pub. L. No. 103-183, 107 Stat. 2226 (Dec. 14, 1993). 
Unenacted bill: Medical Records Confidentiality Act of 1995, S. 1360, 104th Cong., 1st Sess. (1995) 
Code of Federal Regulations: Informed Consent, 42 C.F.R. Sect. 441.257 (1995). 
Hearing: Increased Drug Abuse: the Impact on the Nation's Emergency Rooms: Hearings Before the 
Subcomm. on Human Resources and Intergovernmental Relations of the House Comm. on Government 
Operations, 103rd Cong., 1st Sess. (May 26, 1993). 
28.    Map 
North Carolina. Tuberculosis rates per 100,000 population, 1990 [demo-graphic map]. Raleigh: North 
Carolina Dept. of Environment, Health, and Natural Resources, Div. of Epidemio-logy; 1991. 
29.    Book of the Bible 
The Holy Bible. King James version. Grand Rapids (MI): Zondervan Publishing House; 1995. Ruth 3:1-
18. 
30.    Dictionary and similar references Stedman's medical dictionary. 26th ed. Baltimore: Williams & 
Wilkins; 1995. Apraxia; p. 119-20. 
31.    Classical material 
The Winter's Tale: act 5, scene 1, lines 13-16. The complete works of William Shakespeare. London: 
Rex; 1973. Unpublished Material 
32.    In press 
(Note: NLM prefers "forthcoming" because not all items will be printed.) Leshner AI. Molecular 
mechanisms of cocaine addiction. N Engl J Med. In press 1996. 
Electronic Material 
33.    Journal article in electronic format 
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar 
[cited 1996 Jun 5]; 1(1): [24 screens]. 
  
